Sensitivity of the STAT-VIEW rapid self-test and implications for use during acute HIV infection

被引:3
作者
Boukli, Narjis [1 ]
Boyd, Anders [2 ]
Wendremaire, Noemie [1 ]
Girard, Pierre-Marie [3 ,4 ]
Bottero, Julie [3 ,4 ]
Morand-Joubert, Laurence [1 ,4 ]
机构
[1] Ctr Hosp Univ St Antoine, AP HP, Lab Virol, 184 Rue Faubourg St Antoine, F-75012 Paris, France
[2] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, Paris, France
[3] Ctr Hosp Univ St Antoine, AP HP, Serv Malad Infect, Paris, France
[4] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France
关键词
PERFORMANCE EVALUATION; TRANSMISSION; PLASMA; POINT; CARE;
D O I
10.1136/sextrans-2017-053131
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives HIV testing is an important step towards diminishing incident infections. Rapid self-tests whose use is becoming more common in France could help increase access to testing, yet could fail to diagnose HIV during acute HIV infection (AHI). The aim of the present study was to evaluate HIV-detection sensitivity of a commonly used rapid self-test (STAT-VIEW HIV1/2), compared with another point-of-care rapid test (INSTI), among patients presenting with AHI. Methods Individuals tested at Saint-Antoine Hospital (Paris, France) with negative or indeterminate western blot (WB) results and detectable HIV-RNA were included. Rapid tests were performed retrospectively on stored serum. Patients with and without reactive rapid tests were compared, while probability of having a reactive test was modelled across infection duration using logistic regression. Results Of the 40 patients with AHI, 23 (57.5%) had a reactive STAT-VIEW rapid test. Patients with non-reactive versus reactive tests had a significantly shorter median time since infection (p=0.01), time since onset of symptoms (p=0.009), higher proportion with Fiebig stage III versus IV (p=0.003), negative WB results (p=0.007), higher HIV-RNA levels (p=0.001) and lower CD4+ and CD8+ cell count (p=0.03, p<0.001, respectively). When examining sensitivity over the course of AHI duration, the probability of HIV detection was 75.5% at 5 weeks from HIV transmission. The INSTI provided similar results with respect to proportion of reactive tests (62.5%), determinants for non-reactive test and probability of HIV detection at 5 weeks of infection (85.0%). Conclusions Over half of AHI patients had reactive serology using the STAT-VIEW rapid self-test when performed on serum samples. Considering that detection sensitivity increased substantially over infection time, individuals should not rely on a negative result to accurately exclude HIV infection within at least 5 weeks of potential HIV exposure. Notwithstanding strong recommendations against rapid test use during AHI, some utility in detecting HIV is observed 5-12 weeks after transmission.
引用
收藏
页码:475 / 478
页数:4
相关论文
共 11 条
  • [1] Performance evaluation of the point-of-care INSTI™ HIV-1/2 antibody test in early and established HIV infections
    Adams, Sarah
    Luo, Wei
    Wesolowski, Laura
    Cohen, Stephanie E.
    Peters, Philip J.
    Owen, S. Michele
    Masciotra, Silvina
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2017, 91 : 90 - 94
  • [2] Prevalence and Characteristics of Individuals With Undiagnosed HIV Infection in France: Evidence From a Survey on Hepatitis B and C Seroprevalence
    Cazein, Francoise
    Barin, Francis
    Le Strat, Yann
    Pillonel, Josiane
    Le Vu, Stephane
    Lot, Florence
    Thierry, Damien
    Meffre, Christine
    Semaille, Caroline
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (04) : E114 - E117
  • [3] The Detection of Acute HIV Infection
    Cohen, Myron S.
    Gay, Cynthia L.
    Busch, Michael P.
    Hecht, Frederick M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 202 : S270 - S277
  • [4] Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure
    Delaney, Kevin P.
    Hanson, Debra L.
    Masciotra, Silvina
    Ethridge, Steven F.
    Wesolowski, Laura
    Owen, Sherry Michele
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 64 (01) : 53 - 59
  • [5] Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection
    Fiebig, EW
    Wright, DJ
    Rawal, BD
    Garrett, PE
    Schumacher, RT
    Peddada, L
    Heldebrant, C
    Smith, R
    Conrad, A
    Kleinman, SH
    Busch, MP
    [J]. AIDS, 2003, 17 (13) : 1871 - 1879
  • [6] Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24
    Fitzgerald, Naomi
    Cross, Maria
    O'Shea, Siobhan
    Fox, Julie
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 (02) : 100 - 101
  • [7] HIV transmission rates from persons living with HIV who are aware and unaware of their infection
    Hall, H. Irene
    Holtgrave, David R.
    Maulsby, Catherine
    [J]. AIDS, 2012, 26 (07) : 893 - 896
  • [8] Performance evaluation of the FDA-approved Determine™ HIV-1/2Ag/Ab Combo assay using plasma and whole blood specimens
    Masciotra, Silvina
    Luo, Wei
    Westheimer, Emily
    Cohen, Stephanie E.
    Gay, Cynthia L.
    Hall, Laura
    Pan, Yi
    Peters, Philip J.
    Owen, S. Michele
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2017, 91 : 95 - 100
  • [9] Role of acute and early HIV infection in the sexual transmission of HIV
    Miller, William C.
    Rosenberg, Nora E.
    Rutstein, Sarah E.
    Powers, Kimberly A.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2010, 5 (04) : 277 - 282
  • [10] Accuracy and User-Acceptability of HIV Self-Testing Using an Oral Fluid-Based HIV Rapid Test
    Ng, Oon Tek
    Chow, Angela L.
    Lee, Vernon J.
    Chen, Mark I. C.
    Win, Mar Kyaw
    Tan, Hiok Hee
    Chua, Arlene
    Leo, Yee Sin
    [J]. PLOS ONE, 2012, 7 (09):